Mankind Pharma to acquire Bharat Serums from Advent International for Rs 13,630 cr

Mankind Pharma announced its acquisition of Bharat Serums and Vaccines Limited (BSV) from Advent International for approximately Rs 13,630 crore. This deal positions Mankind Pharma as a leader in the Indian women's health and fertility drug market, expanding its portfolio to include high-entry barrier products in critical care with established R&D technology platforms.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ac7FyeD
via IFTTT